Co-Authors
This is a "connection" page, showing publications co-authored by Antonio Gasbarrini and A Gasbarrini.
Connection Strength
2.995
-
The impact of SARS-CoV-2 pandemic on Oncologic and Degenerative Spine Surgery Department activity: the experience of Rizzoli Orthopaedic Institute under COVID-19 lockdown. Eur Rev Med Pharmacol Sci. 2020 07; 24(13):7519-7523.
Score: 0.890
-
Editorial - COVID-19 pandemic outbreak and the Latin rule of Bernard de Clairvaux. Have we forgotten the past? Eur Rev Med Pharmacol Sci. 2020 06; 24(12):7194-7195.
Score: 0.885
-
Editorial - COVID-19 and the microbiota: new kids on the block. Eur Rev Med Pharmacol Sci. 2020 05; 24(9):5189-5191.
Score: 0.880
-
Web-mediated counseling to counteract the emotional impact of COVID-19 for women with interstitial cystitis/bladder pain syndrome. Eur Rev Med Pharmacol Sci. 2021 Feb; 25(4):2109-2113.
Score: 0.058
-
Prevalence of liver injury and correlation with clinical outcomes in patients with COVID-19: systematic review with meta-analysis. Eur Rev Med Pharmacol Sci. 2020 12; 24(24):13072-13088.
Score: 0.057
-
Surgical emergencies during SARS-CoV-2 pandemic lockdown: what happened? Eur Rev Med Pharmacol Sci. 2020 11; 24(22):11919-11925.
Score: 0.057
-
Mental health and counseling intervention for hereditary hemorrhagic telangiectasia (HHT) during the COVID-19 pandemic: perspectives from Italy. Eur Rev Med Pharmacol Sci. 2020 Oct; 24(19):10225-10227.
Score: 0.057
-
Role of troponin in COVID-19 pandemic: a review of literature. Eur Rev Med Pharmacol Sci. 2020 Oct; 24(19):10293-10300.
Score: 0.057
-
Derivation and validation of a scoring system to assess pre-test probability of being COVID-19 positive. J Infect. 2021 01; 82(1):159-198.
Score: 0.055